TrialClinical cancer research : an official journal of the American Association for Cancer Research2023

FDA Approval Summary: Atezolizumab as Adjuvant Treatment following Surgical Resection and Platinum-Based Chemotherapy for Stage II to IIIA NSCLC.

Luckson N Mathieu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.